OBJECTIVE: Diabetes and obesity are associated with increased plasma nonesterified fatty acid (NEFA) levels, myocardial triglyceride accumulation, and myocardial dysfunction. Because a very low-calorie diet (VLCD) also increases plasma NEFA levels, we studied the effect of a VLCD on myocardial triglyceride content and cardiac function in healthy subjects. RESEARCH DESIGN AND METHODS: Fourteen healthy nonobese men underwent (1)H-magnetic resonance spectroscopy (MRS) to determine myocardial and hepatic triglyceride content, (31)P-MRS to assess myocardial high-energy phosphate (HEP) metabolism (phosphocreatine/ATP), and magnetic resonance imaging of myocardial function at baseline and after a 3-day VLCD. RESULTS: After the dietary intervention, plasma NEFA levels increased compared with those at baseline (from 0.5 +/- 0.1 to 1.1 +/- 0.1 mmol/l, P < 0.05). Concomitantly, myocardial triglyceride content increased by approximately 55% compared with that at baseline (from 0.38 +/- 0.05 to 0.59 +/- 0.06%, P < 0.05), whereas liver triglyceride content decreased by approximately 32% (from 2.2 +/- 0.5 to 1.5 +/- 0.4%, P < 0.05). The VLCD did not change myocardial phosphocreatine-to-ATP ratio (2.33 +/- 0.15 vs. 2.33 +/- 0.08, P > 0.05) or systolic function. Interestingly, deceleration of the early diastolic flow across the mitral valve decreased after the VLCD (from 3.37 +/- 0.20 to 2.91 +/- 0.16 ml/s(2) x 10(-3), P < 0.05). This decrease in diastolic function was significantly correlated with the increase in myocardial triglyceride content. CONCLUSIONS: Short-term VLCD induces accumulation of myocardial triglycerides. In addition, VLCD decreases left ventricular diastolic function, without alterations in myocardial HEP metabolism. This study documents diet-dependent physiological variations in myocardial triglyceride content and diastolic function in healthy subjects.
OBJECTIVE:Diabetes and obesity are associated with increased plasma nonesterified fatty acid (NEFA) levels, myocardial triglyceride accumulation, and myocardial dysfunction. Because a very low-calorie diet (VLCD) also increases plasma NEFA levels, we studied the effect of a VLCD on myocardial triglyceride content and cardiac function in healthy subjects. RESEARCH DESIGN AND METHODS: Fourteen healthy nonobese men underwent (1)H-magnetic resonance spectroscopy (MRS) to determine myocardial and hepatic triglyceride content, (31)P-MRS to assess myocardial high-energy phosphate (HEP) metabolism (phosphocreatine/ATP), and magnetic resonance imaging of myocardial function at baseline and after a 3-day VLCD. RESULTS: After the dietary intervention, plasma NEFA levels increased compared with those at baseline (from 0.5 +/- 0.1 to 1.1 +/- 0.1 mmol/l, P < 0.05). Concomitantly, myocardial triglyceride content increased by approximately 55% compared with that at baseline (from 0.38 +/- 0.05 to 0.59 +/- 0.06%, P < 0.05), whereas liver triglyceride content decreased by approximately 32% (from 2.2 +/- 0.5 to 1.5 +/- 0.4%, P < 0.05). The VLCD did not change myocardial phosphocreatine-to-ATP ratio (2.33 +/- 0.15 vs. 2.33 +/- 0.08, P > 0.05) or systolic function. Interestingly, deceleration of the early diastolic flow across the mitral valve decreased after the VLCD (from 3.37 +/- 0.20 to 2.91 +/- 0.16 ml/s(2) x 10(-3), P < 0.05). This decrease in diastolic function was significantly correlated with the increase in myocardial triglyceride content. CONCLUSIONS: Short-term VLCD induces accumulation of myocardial triglycerides. In addition, VLCD decreases left ventricular diastolic function, without alterations in myocardial HEP metabolism. This study documents diet-dependent physiological variations in myocardial triglyceride content and diastolic function in healthy subjects.
Authors: M Krššák; Y Winhofer; C Göbl; M Bischof; G Reiter; A Kautzky-Willer; A Luger; M Krebs; C Anderwald Journal: Diabetologia Date: 2011-04-15 Impact factor: 10.122
Authors: Jacqueline T Jonker; Marieke Snel; Sebastiaan Hammer; Ingrid M Jazet; Rutger W van der Meer; Hanno Pijl; A Edo Meinders; Albert de Roos; Johannes W A Smit; Johannes A Romijn; Hildo J Lamb Journal: Int J Cardiovasc Imaging Date: 2013-10-16 Impact factor: 2.357
Authors: Leontine E H Bakker; Bruno Guigas; Linda D van Schinkel; Gerard C M van der Zon; Trea C M Streefland; Jan B van Klinken; Jacqueline T Jonker; Hildo J Lamb; Johannes W A Smit; Hanno Pijl; A Edo Meinders; Ingrid M Jazet Journal: Diabetologia Date: 2014-10-15 Impact factor: 10.122
Authors: Zulfia Kisrieva-Ware; Andrew R Coggan; Terry L Sharp; Carmen S Dence; Robert J Gropler; Pilar Herrero Journal: J Nucl Cardiol Date: 2009-02-11 Impact factor: 5.952
Authors: Jacqueline T Jonker; Yanan Wang; Willeke de Haan; Michaela Diamant; Luuk J Rijzewijk; Rutger W van der Meer; Hildo J Lamb; Jouke T Tamsma; Albert de Roos; Johannes A Romijn; Patrick C N Rensen; Johannes W A Smit Journal: Diabetes Care Date: 2010-02-11 Impact factor: 17.152
Authors: Chia-Ying Liu; David A Bluemke; Gary Gerstenblith; Stefan L Zimmerman; Ji Li; Hong Zhu; Shenghan Lai; Hong Lai Journal: Am J Cardiol Date: 2014-06-19 Impact factor: 2.778